Percheron Therapeutics Downgraded to Speculative Hold From Buy by Bell Potter

Dow JonesDec 18, 2024 21:31 ET · Ratings

Percheron Therapeutics Discontinues American Depository Receipt Facility, Uplists to OTCQB

MT NewswiresDec 3, 2024 02:00 ET

Just the Facts: Percheron Hits Milestone in Duchenne Drug Trial | ASX:PER, OTC:PERCF

Proactive InvestorsDec 2, 2024 17:43 ET

Percheron Therapeutics Advances Phase 2b Muscular Dystrophy Clinical Trial; Shares Down 3%

MT NewswiresDec 1, 2024 23:08 ET

Percheron Therapeutics Price Target Cut 7% to A$0.25/Share by Wilsons

Dow JonesNov 7, 2024 16:19 ET · Ratings

Percheron Therapeutics to Raise AU$13 Million via Share Placement; Shares Slump 35%

MT NewswiresOct 17, 2024 21:57 ET